在COVID-19大流行期间治疗结核病:提供行动和病例概况
Luize Barbosa Antunes1, Rubia Laine de Paula Andrade2, Roberta Ramos Ribeiro3
1Universidade Federal de Pelotas (UFPel). Pelotas, Rio Grande do Sul, Brasil.
Revista gaucha de enfermagem
|April 24, 2024
概括
在COVID-19大流行期间,结核病治疗行动对于患有特定疾病的患者来说不太可能. 这凸显了对再治疗病例,并发病症和物质使用的改善后续行动的需要.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 在全球范围内,COVID-19大流行严重影响了医疗保健服务.
- 结核病 (TB) 治疗需要持续的患者监测和具体的诊断行动.
- 医疗保健服务中断可能会影响提供必要的结核病护理.
研究的目的:
- 分析COVID-19大流行期间提供结核病治疗行动和患者特征之间的关联.
- 确定与减少结核病治疗支持相关的社会人口统计和临床因素.
主要方法:
- 一项横截面研究,使用了2020年巴西RS州佩洛塔斯治疗的134例结核病例的二次数据.
- 描述性统计学,奇平方测试和费舍尔精确测试用于数据分析.
主要成果:
- 关键的结核病治疗措施,如多次涂抹显微镜,治疗结束时的显微镜和唾液培养,很少提供.
- 很大一部分患者接受的医疗 (52.9%) 和护理 (83.3%) 咨询次数不到六次.
- 较低的治疗行动提供与再治疗,并发症,艾滋病毒感染,精神障碍,物质使用,正常胸部X射线和特殊治疗方案有关.
结论:
- 在COVID-19大流行时代,基本结核病诊断和护理行动的可用性减少.
- 特定的患者群体,包括患有并发症,艾滋病毒,物质使用和特殊治疗方案的患者,获得的支持较少.
- 疫情后,加强后续对脆弱的结核病患者至关重要,以确保治疗的连续性和有效性.
更多相关视频
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
219
相关概念视频
01:28Pulmonary Tuberculosis V
178
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
178
01:29Pulmonary Tuberculosis I
241
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
241
01:26Pulmonary Tuberculosis IV
140
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
140
01:28Pulmonary Tuberculosis II
226
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
226
01:31Pulmonary Tuberculosis III
324
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
324
01:28Pneumonia IV: Management
323
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
323